⌘K
Loading ticker…
As of 2026-08-24, Glaukos Corporation (GKOS) has a 3-month relative strength percentile of 94 and a leadership percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 72. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.4%, relative volume 0.65×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
GKOS is in a stage 2 uptrend, week 10. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 17.4% / 48.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
GKOS is held by 37 ETFs as of May 2026. Top owner: VTWO at 0.17% weight, $30M notional. Top 3 carry $79M.
Held by 90 ETFs · $1.4B across latest filings · largest weight 3.17% (PSCH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.17% | $30M | −0.05 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.13% | $28M | −0.04 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.35% | $21M | −0.09 pp |
| VHTVanguard Health Care ETF | 0.09% | $18M | — |
| SCHMSchwab U.S. Mid-Cap ETF |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.11% |
| $16M |
| −0.03 pp |
| VTWG | 0.32% | $5M | −0.11 pp |
| VIOGVanguard S&P Small-Cap 600 Growth ETF | 0.48% | $5M | −0.11 pp |
| PSCH | 3.17% | $4M | −0.95 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.21% | $4M | −0.06 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $4M | — |
Showing 10 of 37 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GKOS Jan avg: 8.59% median: 8.87% win: 100% σ: 4.15% n: 4 2022-04-12 → 2026-07-31 | GKOS Feb avg: -6.66% median: -2.10% win: 25% σ: 11.25% n: 4 2022-04-12 → 2026-07-31 | GKOS Mar avg: -4.02% median: -2.25% win: 50% σ: 12.24% n: 4 2022-04-12 → 2026-07-31 | GKOS Apr avg: 0.38% median: -4.24% win: 40% σ: 20.85% n: 5 2022-04-12 → 2026-07-31 | GKOS May avg: -0.85% median: 0.04% win: 60% σ: 20.46% n: 5 2022-04-12 → 2026-07-31 | GKOS Jun avg: 17.18% median: 11.24% win: 100% σ: 12.52% n: 5 2022-04-12 → 2026-07-31 | GKOS Jul avg: 5.71% median: 8.33% win: 60% σ: 15.01% n: 5 2022-04-12 → 2026-07-31 | GKOS Aug avg: 3.28% median: 4.35% win: 50% σ: 11.43% n: 4 2022-04-12 → 2026-07-31 (current) | GKOS Sep avg: -1.95% median: -1.27% win: 50% σ: 10.12% n: 4 2022-04-12 → 2026-07-31 | GKOS Oct avg: 1.36% median: 3.41% win: 75% σ: 7.63% n: 4 2022-04-12 → 2026-07-31 | GKOS Nov avg: 1.51% median: 1.15% win: 50% σ: 16.54% n: 4 2022-04-12 → 2026-07-31 | GKOS Dec avg: 7.21% median: 5.30% win: 75% σ: 12.72% n: 4 2022-04-12 → 2026-07-31 |